Membranous Nephropathy
What's New
Last Posted: Jun 20, 2024
- Association of 10 Polymorphisms in PLA2R1 and HLA DQA1 Genes with Primary Membranous Nephropathy Risk: A Meta-Analysis and a Meta-Regression.
Tarak Dhaouadi, et al. Biomarker insights 2024 0 11772719241259602 - Meta-analysis of the effects of CYP3A5*3 gene polymorphisms on tacrolimus blood concentration and effectiveness in Chinese patients with membranous nephropathy.
Xiaona Dai, et al. Frontiers in pharmacology 2024 0 1385322 - The causal association of specific gut microbiota on the risk of membranous nephropathy: a Mendelian randomization study.
Qiqi Ma, et al. International urology and nephrology 2024 0 - Machine learning model to estimate probability of remission in patients with idiopathic membranous nephropathy.
Lijin Duo et al. Int Immunopharmacol 2023 125(Pt A) 111126 - Clinical Predictive Value of Phospholipase A2 Receptor Gene Polymorphism Combined with Subclass of Immunoglobulin G in Renal Tissues for Membranous Nephropathy.
Chunyang Ji, et al. Alternative therapies in health and medicine 2023 0 - Primary membranous nephropathy in two siblings with one combined with anti-glomerular basement membrane disease: a case report.
Yan-Jiao Cheng, et al. BMC nephrology 2023 0 (1) 183 - A Genetic Risk Score Distinguishes Different Types of Autoantibody-Mediated Membranous Nephropathy.
Sanjana Gupta, et al. Glomerular diseases 2023 0 (1) 116-125 - Association between PLA2R gene polymorphism and idiopathic membranous nephropathy in Heilongjiang Chinese.
Tian Tian, et al. Annals of translational medicine 2023 0 (3) 148 - Kidney Disease Progression in Membranous Nephropathy among Black Participants with High-Risk APOL1 Genotype.
Chen Dhruti P, et al. Clinical journal of the American Society of Nephrology : CJASN 2023 0 (3) 337-343 - Worsened Outcome in Patients with Membranous Nephropathy Carrying Apolipoprotein L1 High-Risk Genotype.
Susztak Katalin, et al. Clinical journal of the American Society of Nephrology : CJASN 2023 0 (3) 303-305 - Genetics of membranous nephropathy.
Gupta Sanjana, et al. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2017 0 (9) 1493-1502 - Deep pockets are not necessarily a good thing in membranous nephropathy: evidence for a modifier allele.
Beck Laurence H, et al. Kidney international 2018 0 (5) 855-857 - The Genetic and Environmental Factors of Primary Membranous Nephropathy: An Overview from China.
Zhang Xiao-Dan, et al. Kidney diseases (Basel, Switzerland) 2018 0 (2) 65-73 - Primary glomerular nephropathy among hospitalized patients in a national database in China.
Li Jiannan, et al. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2018 0 (12) 2173-2181 - Clinical observation on the effect of Wuzhi soft capsule on FK506 concentration in membranous nephropathy patients.
Zhang Zhu, et al. Medicine 2019 0 (48) e18150 - Association of SNPs in PLA2R1 with idiopathic and secondary membranous nephropathy in two Chinese cohorts.
Tian C X, et al. British journal of biomedical science 2019 0 (1) 24-28 - Identical twins with idiopathic membranous nephropathy.
Tao Tian, et al. Journal of nephrology 2020 0 (2) 597-601 - The Role of HBx Gene Mutations in PLA R Positive Hepatitis-B-associated Membranous Nephropathy.
Dong Hui, et al. Biomedical and environmental sciences : BES 2020 0 (4) 269-272 - Effects of CYP3A5 Polymorphisms on Efficacy and Safety of Tacrolimus Therapy in Patients with Idiopathic Membranous Nephropathy.
Zhang Chengning, et al. Pharmacogenomics and personalized medicine 2020 0 141-149 - Corrigendum to Berchtold L, Letouzé E, Alexander MP, et al. HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients. Kidney Int. 2021;99:671-685.
Berchtold Lena, et al. Kidney international 2021 0 (1) 243 - HLA Alleles and Prognosis of PLA2R-Related Membranous Nephropathy.
Le Wei-Bo, et al. Clinical journal of the American Society of Nephrology : CJASN 2021 0 (8) 1221-1227 - The association between variants in PLA2R and HLA-DQA1 and renal outcomes in patients with primary membranous nephropathy in Western China.
Fan Shulei, et al. BMC medical genomics 2021 0 (1) 123 - PLA2R1 and HLA-DQA1 gene variations in idiopathic membranous nephropathy in South China.
Wang Fan, et al. Annals of the Academy of Medicine, Singapore 2021 0 (1) 33-41 - Investigation of pharmacologic interactions between omeprazole and tacrolimus in a membranous nephropathy patient with CYP3A5 nonexpresser: a case report.
Li Yanli, et al. Pharmacogenetics and genomics 2022 0 (7) 268-271 - Non-diabetic urine glucose in idiopathic membranous nephropathy.
Liu Lingling, et al. Renal failure 2022 0 (1) 1104-1111 - NR3C1 Glucocorticoid Receptor Gene Polymorphisms Are Associated with Membranous and IgA Nephropathies.
Pac Micha?, et al. Cells 2021 0 (11) - One Actor, Many Roles: Histopathologies Associated With APOL1 Genetic Variants.
Kopp Jeffrey B, et al. Advances in anatomic pathology 2019 0 (3) 215-219 - The Efficacy of Cyclophosphamide Combined with Prednisone in Membranous Nephropathy Patients with Different Cytochrome P450 2B6 Gene Polymorphisms and Analysis of Factors Influencing the Efficacy.
Zhang Min, et al. Drug design, development and therapy 2022 0 3655-3662 - Associations between m-type phospholipase A2 receptor,human leukocyte antigen gene polymorphisms and idiopathic membranous nephropathy.
Liu Xiaogang, et al. Bioengineered 2021 10 - Identification of a Locus on the X Chromosome Linked to Familial Membranous Nephropathy.
Downie Mallory L, et al. Kidney international reports 2021 6 (6) 1669-1676 - Association between PLA2R1 rs4664308 and susceptibility to idiopathic membranous nephropathy: Protocol for a systematic review and meta-analysis of case-control studies.
Qiu Jing Yi, et al. Medicine 2020 11 (45) e22908 - HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients.
Berchtold Lena, et al. Kidney international 2020 9 - Single-nucleotide polymorphism rs4664308 in PLA2R1 gene is associated with the risk of idiopathic membranous nephropathy: a meta-analysis.
Yoshikawa Masahiro, et al. Scientific reports 2020 8 (1) 13119 - The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis.
Xie Jingyuan, et al. Nature communications 2020 0 (1) 1600 - Association between the HLA-DQA1 rs2187668 polymorphism and risk of idiopathic membranous nephropathy: A PRISMA-compliant meta-analysis.
Bao Liping, et al. Medicine 2018 11 (44) e13031 - Identification of a two-SNP PLA2R1 Haplotype and HLA-DRB1 Alleles as Primary Risk Associations in Idiopathic Membranous Nephropathy.
Latt Khun Zaw, et al. Scientific reports 2018 10 (1) 15576 - Interaction between PLA2R1 and HLA-DQA1 variants contributes to the increased genetic susceptibility to membranous nephropathy in Western China.
Wang Wei, et al. Nephrology (Carlton, Vic.) 2018 11 - HLA class II alleles differing by a single amino acid associate with clinical phenotype and outcome in patients with primary membranous nephropathy.
Wang Huai-Yu, et al. Kidney international 2018 0 (5) 974-982 - Low a-defensin gene copy number increases the risk for IgA nephropathy and renal dysfunction.
Ai Zhen, et al. Science translational medicine 2016 0 (345) 345ra88 - Phospholipase A2 Receptor-Related Membranous Nephropathy and Mannan-Binding Lectin Deficiency.
Bally Stéphane, et al. Journal of the American Society of Nephrology : JASN 2016 12 (12) 3539-3544
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: